• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    3/28/22 11:44:08 AM ET
    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGTC alert in real time by email

     

     

    On Monday, 147 stocks hit new 52-week lows.

    Areas of Significance In Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Stanley Black & Decker (NYSE:SWK).
    • Vallon Pharmaceuticals (NASDAQ:VLON) was the smallest firm by market cap to set a new 52-week low.
    • Amylyx Pharmaceuticals (NASDAQ:AMLX) saw the most significant move of the companies, as shares traded down 53.24% to reach its new 52-week low.
    • Invesco California Value (NYSE:VCV) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low.

    During Monday, the following stocks broke to new 52-week lows:

    • CarMax (NYSE:KMX) stock achieved a new 52-week low on Monday morning, hitting $95.04 and moving down 1.31%.
    • Whirlpool (NYSE:WHR) shares moved up 0.43% on Monday to hit a new 52-week low of $180.26, drifting up 0.43%.
    • Nuveen AMT-Free Municipal (NYSE:NEA) stock achieved a new 52-week low on Monday morning, hitting $12.79 and moving down 0.89%.
    • Safehold (NYSE:SAFE) shares hit a yearly low of $53.73. The stock was down 0.66% on the session.
    • Nuveen Quality Municipal (NYSE:NAD) shares moved down 0.76% on Monday to hit a new 52-week low of $13.07, drifting down 0.76%.
    • Meritage Homes (NYSE:MTH) stock drifted down 0.11% on Monday morning to hit a new 52-week low of $81.63.
    • Nuveen AMT-Free Municipal (NYSE:NVG) stock broke to a new 52-week low of $14.15 on Monday. Shares of the company traded down 1.11%.
    • M.D.C. Holdings (NYSE:MDC) shares were up 0.08% for the day, having made a 52-week low of $38.62.
    • Vir Biotechnology (NASDAQ:VIR) shares fell to $20.55 on Monday, setting a new 52-week low with a shift of down 5.04%.
    • LCI Indus (NYSE:LCII) stock hit a new 52-week low of $102.47. The stock was down 2.32% on the session.
    • Kennametal (NYSE:KMT) shares moved down 3.59% on Monday to hit a new 52-week low of $28.20, drifting down 3.59%.
    • Nuveen Municipal Credit (NYSE:NZF) stock hit a yearly low of $13.86. The stock was down 1.42% for the day.
    • Winnebago Industries (NYSE:WGO) shares made a new 52-week low of $52.67 on Monday. The stock was down 2.07% for the day.
    • Sally Beauty Holdings (NYSE:SBH) shares hit a yearly low of $15.17. The stock was down 0.93% on the session.
    • Blackrock Municipal 2030 (NYSE:BTT) shares reached a new 52-week low of $23.24 on Monday morning, moving down 1.19%.
    • LumiraDx (NASDAQ:LMDX) stock achieved a new 52-week low on Monday morning, hitting $4.61 and moving down 30.8%.
    • Nuveen Municipal High Inc (NYSE:NMZ) stock set a new 52-week low of $12.89 on Monday, moving down 0.69%.
    • Griffon (NYSE:GFF) stock broke to a new 52-week low of $20.31 on Monday. Shares of the company traded down 0.29%.
    • Blackrock Muniyield (NYSE:MQY) stock drifted down 0.67% on Monday morning to hit a new 52-week low of $13.32.
    • Sonder Holdings (NASDAQ:SOND) stock dropped to a yearly low on Monday of $4.08. Shares traded down 4.63%.
    • BLACKROCK MUNIYIELD (NYSE:MYI) shares were down 1.29% for the day, having made a 52-week low of $12.19.
    • Orion Office REIT (NYSE:ONL) shares moved down 4.79% on Monday to hit a new 52-week low of $14.00, drifting down 4.79%.
    • Nuveen Dynamic Municipal (NYSE:NDMO) shares set a new 52-week low of $13.00. The stock traded down 0.53%.
    • Invesco Municipal (NYSE:VMO) shares fell to $10.91 on Monday, setting a new 52-week low with a shift of down 0.09%.
    • Blackrock Muniholdings (NYSE:MHD) shares set a new 52-week low of $13.68. The stock traded down 0.44%.
    • Torrid Holdings (NYSE:CURV) stock hit a new 52-week low of $6.72. The stock was down 2.18% on the session.
    • Nuveen Municipal Credit (NYSE:NMCO) shares were down 0.83% for the day, having made a 52-week low of $13.14.
    • Amylyx Pharmaceuticals (NASDAQ:AMLX) shares made a new 52-week low of $10.49 on Monday. The stock was down 53.24% for the day.
    • Nuveen Intermediate Dur (NYSE:NID) stock hit a new 52-week low of $13.47. The stock was down 0.59% on the session.
    • Invesco Value Municipal (NYSE:IIM) stock achieved a new 52-week low on Monday morning, hitting $13.41 and moving down 0.39%.
    • Invesco Trust (NYSE:VGM) stock hit $11.25 on Monday morning, setting a new 52-week low for a change of down 0.53%.
    • Blackrock Muniyield Fund (NYSE:MYD) shares set a new 52-week low of $12.11. The stock traded down 0.9%.
    • Volta (NYSE:VLTA) stock hit $3.38 on Monday morning, setting a new 52-week low for a change of down 15.79%.
    • Blackstone Strategic (NYSE:BGB) stock achieved a new 52-week low on Monday morning, hitting $12.53 and moving down 0.24%.
    • Nuveen New Jersey Quality (NYSE:NXJ) shares were up 0.23% for the day, having made a 52-week low of $13.16.
    • Blackrock Municipal IT (NYSE:BFK) shares were down 1.39% for the day, having made a 52-week low of $12.05.
    • America's Car-Mart (NASDAQ:CRMT) shares were down 0.64% for the day, having made a 52-week low of $82.53.
    • Invesco California Value (NYSE:VCV) stock hit a yearly low of $10.89. The stock was 0.0% (flat) for the day.
    • Blackrock Munivest Fund (NYSE:MVF) stock drifted down 0.62% on Monday morning to hit a new 52-week low of $7.97.
    • MainStay MacKay (NYSE:MMD) shares were down 0.36% for the day, having made a 52-week low of $18.30.
    • Solo Brands (NYSE:DTC) stock drifted down 1.47% on Monday morning to hit a new 52-week low of $7.80.
    • Nuveen Pennsylvania (NYSE:NQP) shares hit a yearly low of $13.36. The stock was down 0.45% on the session.
    • Incannex Healthcare (NASDAQ:IXHL) stock achieved a new 52-week low on Monday morning, hitting $10.20 and moving down 8.35%.
    • Blackrock Muni Interm (NYSE:MUI) shares set a new yearly low of $12.82 this morning. The stock was down 0.77% on the session.
    • Vicarious Surgical (NYSE:RBOT) stock achieved a new 52-week low on Monday morning, hitting $4.10 and moving down 6.13%.
    • Cullinan Oncology (NASDAQ:CGEM) shares reached a new 52-week low of $10.75 on Monday morning, moving down 5.4%.
    • Sophia Genetics (NASDAQ:SOPH) stock hit $7.12 on Monday morning, setting a new 52-week low for a change of down 0.13%.
    • Blackrock Muniyield NY (NYSE:MYN) stock broke to a new 52-week low of $11.78 on Monday. Shares of the company traded down 1.33%.
    • Eaton Vance Municipal IT (NYSE:EVN) shares reached a new 52-week low of $11.61 on Monday morning, moving down 1.69%.
    • Singular Genomics Sys (NASDAQ:OMIC) shares fell to $5.86 on Monday, setting a new 52-week low with a shift of up 0.17%.
    • Loyalty Ventures (NASDAQ:LYLT) stock hit $16.64 on Monday morning, setting a new 52-week low for a change of down 4.59%.
    • Putnam Municipal Opps (NYSE:PMO) stock set a new 52-week low of $11.50 on Monday, moving down 0.48%.
    • Nuveen New York Quality (NYSE:NAN) shares moved down 0.49% on Monday to hit a new 52-week low of $12.22, drifting down 0.49%.
    • Blackrock Muniyield (NYSE:MIY) stock hit $12.41 on Monday morning, setting a new 52-week low for a change of down 1.64%.
    • BNY Mellon Strategic (NYSE:DSM) stock dropped to a yearly low on Monday of $6.90. Shares traded down 1.36%.
    • PIMCO Municipal Income (NYSE:PMX) stock set a new 52-week low of $10.05 on Monday, moving down 1.37%.
    • Omega Therapeutics (NASDAQ:OMGA) shares hit a yearly low of $6.50. The stock was down 4.01% on the session.
    • Blackrock Muniyield NJ (NYSE:MYJ) stock hit a yearly low of $13.10. The stock was 0.0% (flat) for the day.
    • Nuveen Enhanced Municipal (NYSE:NEV) shares fell to $12.68 on Monday, setting a new 52-week low with a shift of down 0.94%.
    • PIMCO Municipal Income (NYSE:PMF) stock hit a new 52-week low of $11.88. The stock was down 0.33% on the session.
    • Kimball International (NASDAQ:KBAL) shares moved down 1.64% on Monday to hit a new 52-week low of $8.39, drifting down 1.64%.
    • Graphite Bio (NASDAQ:GRPH) stock hit $5.06 on Monday morning, setting a new 52-week low for a change of down 3.9%.
    • Zymergen (NASDAQ:ZY) shares reached a new 52-week low of $2.86 on Monday morning, moving down 5.88%.
    • Gritstone Bio (NASDAQ:GRTS) stock drifted down 1.35% on Monday morning to hit a new 52-week low of $4.01.
    • BlackRock MuniHoldings (NYSE:MUE) stock dropped to a yearly low on Monday of $11.59. Shares traded down 0.62%.
    • Nuveen Ohio Quality (NYSE:NUO) stock broke to a new 52-week low of $13.73 on Monday. Shares of the company traded down 0.39%.
    • Blackrock Investment (NYSE:BKN) shares set a new yearly low of $14.39 this morning. The stock was down 1.33% on the session.
    • Eaton Vance California (AMEX:EVM) shares set a new 52-week low of $9.74. The stock traded down 0.61%.
    • Vor Biopharma (NASDAQ:VOR) stock broke to a new 52-week low of $6.30 on Monday. Shares of the company traded down 6.12%.
    • Pioneer Municipal High IT (NYSE:MHI) stock achieved a new 52-week low on Monday morning, hitting $10.30 and moving down 0.63%.
    • Rallybio (NASDAQ:RLYB) stock hit $6.76 on Monday morning, setting a new 52-week low for a change of 0.0% (flat).
    • Territorial Bancorp (NASDAQ:TBNK) stock set a new 52-week low of $23.67 on Monday, moving down 3.22%.
    • Curis (NASDAQ:CRIS) stock broke to a new 52-week low of $2.36 on Monday. Shares of the company traded down 3.84%.
    • Vigil Neuroscience (NASDAQ:VIGL) shares set a new yearly low of $6.86 this morning. The stock was down 4.47% on the session.
    • InfuSystems Holdings (AMEX:INFU) stock achieved a new 52-week low on Monday morning, hitting $9.50 and moving down 1.74%.
    • Barnes & Noble Education (NYSE:BNED) shares fell to $3.45 on Monday, setting a new 52-week low with a shift of down 7.97%.
    • Invesco Bond (NYSE:VBF) shares were up 0.15% for the day, having made a 52-week low of $16.89.
    • Eaton Vance New York (AMEX:ENX) shares hit a yearly low of $10.26. The stock was down 0.39% on the session.
    • MISTRAS Group (NYSE:MG) shares fell to $6.03 on Monday, setting a new 52-week low with a shift of down 0.82%.
    • Shattuck Labs (NASDAQ:STTK) stock hit a new 52-week low of $4.19. The stock was down 4.1% on the session.
    • CytomX Therapeutics (NASDAQ:CTMX) stock hit a new 52-week low of $2.58. The stock was down 2.6% on the session.
    • Blackrock Muniyield (NYSE:MPA) stock set a new 52-week low of $12.78 on Monday, moving down 0.19%.
    • Icosavax (NASDAQ:ICVX) shares hit a yearly low of $4.00. The stock was down 3.29% on the session.
    • Quanergy Systems (NYSE:QNGY) stock drifted down 1.98% on Monday morning to hit a new 52-week low of $1.97.
    • BioAtla (NASDAQ:BCAB) shares hit a yearly low of $4.28. The stock was down 2.8% on the session.
    • CarLotz (NASDAQ:LOTZ) shares moved down 4.05% on Monday to hit a new 52-week low of $1.41, drifting down 4.05%.
    • Paratek Pharmaceuticals (NASDAQ:PRTK) shares set a new yearly low of $2.89 this morning. The stock was up 2.04% on the session.
    • Blackrock Long-term (NYSE:BTA) stock hit $11.40 on Monday morning, setting a new 52-week low for a change of down 0.84%.
    • Nuveen Arizona Quality (NYSE:NAZ) stock set a new 52-week low of $13.16 on Monday, moving down 0.26%.
    • Athersys (NASDAQ:ATHX) shares hit a yearly low of $0.61. The stock was down 4.81% on the session.
    • Helix Acquisition (NASDAQ:HLXA) stock achieved a new 52-week low on Monday morning, hitting $9.60 and moving down 0.81%.
    • EMCORE (NASDAQ:EMKR) stock hit a new 52-week low of $3.50. The stock was up 0.14% on the session.
    • Western Asset Municipal (NYSE:MNP) stock broke to a new 52-week low of $13.20 on Monday. Shares of the company traded down 0.98%.
    • Biomea Fusion (NASDAQ:BMEA) stock set a new 52-week low of $4.21 on Monday, moving down 5.51%.
    • CVRx (NASDAQ:CVRX) shares set a new 52-week low of $5.51. The stock traded up 2.31%.
    • Nautilus (NYSE:NLS) stock hit $3.92 on Monday morning, setting a new 52-week low for a change of down 1.61%.
    • Dirtt Environmental Solns (NASDAQ:DRTT) shares made a new 52-week low of $1.42 on Monday. The stock was down 2.7% for the day.
    • Nuveen Select Maturities (NYSE:NIM) shares made a new 52-week low of $9.51 on Monday. The stock was down 0.63% for the day.
    • Annexon (NASDAQ:ANNX) stock hit a yearly low of $3.01. The stock was down 6.44% for the day.
    • Gaia (NASDAQ:GAIA) stock achieved a new 52-week low on Monday morning, hitting $4.91 and moving down 0.63%.
    • Esports Technologies (NASDAQ:EBET) shares made a new 52-week low of $6.20 on Monday. The stock was down 5.93% for the day.
    • DTFTax-Free Income (NYSE:DTF) stock broke to a new 52-week low of $12.64 on Monday. Shares of the company traded down 0.82%.
    • Eaton Vance CA Muni (AMEX:CEV) stock dropped to a yearly low on Monday of $11.32. Shares traded down 0.22%.
    • Reneo Pharmaceuticals (NASDAQ:RPHM) stock dropped to a yearly low on Monday of $3.20. Shares traded down 2.95%.
    • MEI Pharma (NASDAQ:MEIP) stock drifted down 8.17% on Monday morning to hit a new 52-week low of $0.57.
    • Vericity (NASDAQ:VERY) stock set a new 52-week low of $4.14 on Monday, moving down 0.99%.
    • Neoleukin Therapeutics (NASDAQ:NLTX) stock hit a yearly low of $1.71. The stock was down 4.95% for the day.
    • Angel Oak Dynamic (NYSE:DYFN) shares set a new yearly low of $17.94 this morning. The stock was down 1.27% on the session.
    • Sensei Biotherapeutics (NASDAQ:SNSE) shares set a new 52-week low of $2.23. The stock traded down 2.59%.
    • Neuberger Berman CA Muni (AMEX:NBW) stock hit $12.11 on Monday morning, setting a new 52-week low for a change of down 0.13%.
    • Applied Genetic (NASDAQ:AGTC) stock broke to a new 52-week low of $1.14 on Monday. Shares of the company traded down 5.73%.
    • Biodesix (NASDAQ:BDSX) stock dropped to a yearly low on Monday of $1.71. Shares traded down 5.65%.
    • LiqTech International (NASDAQ:LIQT) shares set a new yearly low of $2.52 this morning. The stock was down 2.67% on the session.
    • Better Therapeutics (NASDAQ:BTTX) stock broke to a new 52-week low of $2.12 on Monday. Shares of the company traded down 2.28%.
    • Pennsylvania REIT (NYSE:PEI) shares set a new yearly low of $0.62 this morning. The stock was down 6.55% on the session.
    • Nuveen NY Select Tax-Free (NYSE:NXN) shares set a new yearly low of $12.25 this morning. The stock was down 0.73% on the session.
    • Minim (NASDAQ:MINM) stock hit $0.86 on Monday morning, setting a new 52-week low for a change of down 2.19%.
    • Borqs Technologies (NASDAQ:BRQS) shares were down 4.32% for the day, having made a 52-week low of $0.21.
    • Allena Pharmaceuticals (NASDAQ:ALNA) stock drifted down 10.01% on Monday morning to hit a new 52-week low of $0.22.
    • Vallon Pharmaceuticals (NASDAQ:VLON) stock achieved a new 52-week low on Monday morning, hitting $1.93 and moving down 2.94%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AGTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGTC
    $ALNA
    $AMLX
    $ANNX

    CompanyDatePrice TargetRatingAnalyst
    Cullinan Therapeutics Inc.
    $CGEM
    2/2/2026$30.00Buy
    Guggenheim
    Shattuck Labs Inc.
    $STTK
    1/28/2026$15.00Overweight
    Piper Sandler
    Safehold Inc. New
    $SAFE
    1/23/2026$14.00Equal-Weight → Underweight
    Morgan Stanley
    LCI Industries
    $LCII
    1/22/2026$149.00Buy → Hold
    Loop Capital
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/21/2026$19.00Mkt Perform → Outperform
    Raymond James
    CytomX Therapeutics Inc.
    $CTMX
    1/20/2026$10.00Buy
    Guggenheim
    Meritage Homes Corporation
    $MTH
    1/16/2026$82.00Buy → Neutral
    BofA Securities
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/14/2026$16.00Buy → Hold
    Jefferies
    More analyst ratings

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Cullinan Therapeutics with a new price target

    Guggenheim initiated coverage of Cullinan Therapeutics with a rating of Buy and set a new price target of $30.00

    2/2/26 6:51:16 AM ET
    $CGEM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Piper Sandler initiated coverage on Shattuck Labs with a new price target

    Piper Sandler initiated coverage of Shattuck Labs with a rating of Overweight and set a new price target of $15.00

    1/28/26 7:19:49 AM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Safehold downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Safehold from Equal-Weight to Underweight and set a new price target of $14.00

    1/23/26 8:14:28 AM ET
    $SAFE
    Real Estate Investment Trusts
    Real Estate

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Emeritus Director Schuler Jack W bought $1,180,736 worth of shares (100,000 units at $11.81) (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    1/27/26 9:29:02 AM ET
    $BDSX
    Medical Specialities
    Health Care

    Emeritus Director Schuler Jack W bought $903,561 worth of shares (82,465 units at $10.96) (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    1/26/26 9:28:57 AM ET
    $BDSX
    Medical Specialities
    Health Care

    Large owner Bank Of America Corp /De/ bought $76,606 worth of shares (6,075 units at $12.61) and sold $76,029 worth of shares (6,075 units at $12.52) (SEC Form 4)

    4 - Nuveen Municipal Credit Income Fund (0001137887) (Issuer)

    1/5/26 1:28:46 PM ET
    $NZF
    Finance Companies
    Finance

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    SEC Filings

    View All

    BioAtla Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure

    8-K - BioAtla, Inc. (0001826892) (Filer)

    2/6/26 5:02:26 PM ET
    $BCAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Biomea Fusion Inc.

    SCHEDULE 13G/A - Biomea Fusion, Inc. (0001840439) (Subject)

    2/6/26 4:30:02 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by Biodesix Inc.

    S-8 - BIODESIX INC (0001439725) (Filer)

    2/6/26 4:14:20 PM ET
    $BDSX
    Medical Specialities
    Health Care

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium

    AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that company management will participate in a fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium, taking place February 12-13, 2026. Conference Details Conference: Piper Sandler Virtual Novel Targets in Immunology SymposiumFormat: Fireside chat Presenters: Taylor Schreiber, M.D., Ph.D., Chief Executive Officer, Andr

    2/6/26 8:30:00 AM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Winnebago Industries, Inc. Announces Redemption of $100,000,000 of Its 6.25% Senior Secured Notes Due 2028

    EDEN PRAIRIE, Minn., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE:WGO), a leading manufacturer of outdoor recreation products, today announced that it will redeem $100,000,000 of the outstanding $200,000,000 aggregate principal amount of its 6.250% Senior Secured Notes due 2028 (the "Notes") on February 20, 2026. Pursuant to the terms of the indenture governing the Notes, the company will redeem the outstanding Notes at a redemption price of 100% of their principal amount, plus accrued and unpaid interest to, but not including, the redemption date. "This redemption reflects our stated focus on improving balance sheet leverage while continuing to generate cash flow an

    2/5/26 4:15:00 PM ET
    $WGO
    Homebuilding
    Industrials

    Griffon Corporation Announces First Quarter Results

    Griffon Corporation ("Griffon" or the "Company") (NYSE:GFF) today reported results for the fiscal 2026 first quarter ended December 31, 2025. Revenue for the first quarter totaled $649.1 million, a 3% increase compared to $632.4 million in the prior year quarter. Net income totaled $64.4 million, or $1.41 per share, compared to $70.9 million, or $1.49 per share, in the prior year quarter. Excluding all items that affect comparability from both periods, adjusted net income (a non-GAAP measure) was $66.3 million, or $1.45 per share, in the current year quarter compared to $65.9 million, or $1.39 per share, in the prior year quarter. For a reconciliation of net income to adjusted net incom

    2/5/26 7:33:00 AM ET
    $GFF
    Building Products
    Industrials

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Erdtmann Rainer M decreased direct ownership by 21% to 572,427 units (SEC Form 5)

    5 - Biomea Fusion, Inc. (0001840439) (Issuer)

    2/6/26 4:15:03 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Business Officer Lester Rachael was granted 20,000 shares (SEC Form 4)

    4 - CytomX Therapeutics, Inc. (0001501989) (Issuer)

    2/4/26 4:28:36 PM ET
    $CTMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Chu Yu-Waye was granted 75,000 shares, increasing direct ownership by 55% to 210,725 units (SEC Form 4)

    4 - CytomX Therapeutics, Inc. (0001501989) (Issuer)

    2/4/26 4:27:02 PM ET
    $CTMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 29, 2022 - FDA Approves New Treatment Option for Patients with ALS

    For Immediate Release: September 29, 2022 The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.  “This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure,” said Billy Dunn, M.D., director of the Off

    9/29/22 5:02:14 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 2, 2022 - FDA Roundup: September 2, 2022

    For Immediate Release: September 02, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:   On Thursday, the FDA published the FDA Voices: “Using A Whole-Of-Governments Approach to Combating Illicit Health Products,” by Cathy Hermsen, Assistant Commissioner for Criminal Investigations and Ritu Nalubola, Director of the FDA’s Europe Office. Crimi

    9/2/22 1:46:13 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NUZYRA issued to PARATEK PHARMS INC

    Submission status for PARATEK PHARMS INC's drug NUZYRA (SUPPL-11) with active ingredient OMADACYCLINE TOSYLATE has changed to 'Approval' on 05/27/2021. Application Category: NDA, Application Number: 209816, Application Classification: Efficacy

    5/31/21 5:18:25 AM ET
    $PRTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Pioneer Municipal High Income Fund Inc.

    SC 13D/A - PIONEER MUNICIPAL HIGH INCOME FUND, INC. (0001223026) (Subject)

    12/13/24 4:29:09 PM ET
    $MHI
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by BNY Mellon Strategic Municipal Bond Fund Inc.

    SC 13D/A - BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC. (0000855887) (Subject)

    12/13/24 4:29:05 PM ET
    $DSM
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by Nuveen Quality Municipal Income Fund

    SC 13D/A - Nuveen Quality Municipal Income Fund (0001083839) (Subject)

    12/13/24 4:15:39 PM ET
    $NAD
    Investment Managers
    Finance

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Leadership Updates

    Live Leadership Updates

    View All

    CRAFTSMAN® Kicks Off Championship Sunday with Chances to Win Prize Packs Totaling $20,000 in its "V20* Yard Line Giveaway" on Instagram Live

    Enter the Game within the Game: Fans following the excitement on Instagram Live at @Craftsman can enter for a chance to win by commenting "V20 Giveaway" each time the ball enters the red zone. CRAFTSMAN has teamed up with creators including Isaac Rochell, Darien Rencher, Christina Roki, Grant Sloan, and the #CRAFTSMANCrew to join the action live.TOWSON, Md., Feb. 2, 2026 /PRNewswire/ -- This Championship Sunday, CRAFTSMAN®, the legendary tool brand from Stanley Black & Decker, is bringing fans closer to the action with a live, gamified giveaway that turns every red zone drive into a chance to win big. For the first time ever, CRAFTSMAN is launching a "game within the game" on Instagram, givi

    2/2/26 9:00:00 AM ET
    $SWK
    Industrial Machinery/Components
    Consumer Discretionary

    Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

    MELBOURNE, Australia and NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced the appointment of three additional members to its recently established Clinical Advisory Board ("CAB"): Murray B. Stein, MD, MPH; Andrew Cutler, MD; and Amir Kalali, MD. The CAB was formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The addition of Drs. Stein, Cutler, and Kalali further strengthens the Board's expertise across psychiatry, neurobiology, psychopharmacology, an

    1/29/26 8:00:00 AM ET
    $IXHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

    SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced a leadership transition designed to support the Company's next phase of growth and advancement toward late-stage development and key clinical and corporate milestones. Mani Mohindru, PhD, a member of Cardiff Oncology's Board of Directors since 2021 and a seasoned biotech executive, has been appointed interim Chief Executive Officer, effective immediately. Mark Erlander, PhD, Chief Executive Officer, and James Levine, Chief Financial Officer, have stepped down from their res

    1/27/26 7:00:00 AM ET
    $CRDF
    $CTMX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AGTC
    $ALNA
    $AMLX
    $ANNX
    Financials

    Live finance-specific insights

    View All

    Griffon Corporation Announces First Quarter Results

    Griffon Corporation ("Griffon" or the "Company") (NYSE:GFF) today reported results for the fiscal 2026 first quarter ended December 31, 2025. Revenue for the first quarter totaled $649.1 million, a 3% increase compared to $632.4 million in the prior year quarter. Net income totaled $64.4 million, or $1.41 per share, compared to $70.9 million, or $1.49 per share, in the prior year quarter. Excluding all items that affect comparability from both periods, adjusted net income (a non-GAAP measure) was $66.3 million, or $1.45 per share, in the current year quarter compared to $65.9 million, or $1.39 per share, in the prior year quarter. For a reconciliation of net income to adjusted net incom

    2/5/26 7:33:00 AM ET
    $GFF
    Building Products
    Industrials

    Griffon Corporation Declares Quarterly Dividend

    The Board of Directors of Griffon Corporation (NYSE:GFF) (the "Company" or "Griffon") yesterday declared a regular quarterly cash dividend of $0.22 per share. The dividend is payable on March 18, 2026 to shareholders of record as of the close of business on February 27, 2026. About Griffon Corporation Griffon is a diversified management and holding company that conducts business through wholly-owned subsidiaries. Griffon oversees the operations of its subsidiaries, allocates resources among them and manages their capital structures. Griffon provides direction and assistance to its subsidiaries in connection with acquisition and growth opportunities as well as divestitures. As long-term

    2/5/26 7:30:00 AM ET
    $GFF
    Building Products
    Industrials

    LCI Industries Fourth Quarter and Full Year 2025 Conference Call Scheduled for February 18, 2026, at 8:30 a.m. ET

    LCI Industries (NYSE:LCII), a leading supplier of engineered components to the recreation and transportation markets, will release its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February 18, 2026. Conference Call & Webcast LCI Industries will also host a conference call and webcast to discuss its fourth quarter and full year 2025 results on Wednesday, February 18, 2026, at 8:30 a.m. ET. An online, real-time webcast, as well as a supplemental earnings presentation, will be available on the Company's website, www.investors.lci1.com. The conference call and webcast can also be accessed by dialing (833) 470-1428 for participants in the U.S. a

    2/4/26 8:00:00 AM ET
    $LCII
    Auto Parts:O.E.M.
    Consumer Discretionary